Literature DB >> 24464559

Mutational Spectrum of the CTNS Gene in Egyptian Patients with Nephropathic Cystinosis.

Neveen A Soliman1, Mohamed A Elmonem, Lambertus van den Heuvel, Rehab H Abdel Hamid, Mohamed Gamal, Inge Bongaers, Sandrine Marie, Elena Levtchenko.   

Abstract

BACKGROUND: Nephropathic cystinosis is a rare autosomal recessive disorder caused by mutations in the CTNS gene, encoding for cystinosin, a carrier protein transporting cystine out of lysosomes. Its deficiency leads to cystine accumulation and cell damage in multiple organs, especially in the kidney. In this study, we aimed to provide the first report describing the mutational spectrum of Egyptian patients with nephropathic cystinosis and their genotype-phenotype correlation.
METHODS: Fifteen Egyptian patients from 13 unrelated families with infantile nephropathic cystinosis were evaluated clinically, biochemically, and genetically. Screening for the common 57-kb deletion was performed by standard multiplex PCR, followed by direct sequencing of the ten coding exons, exon-intron interfaces, and promoter region.
RESULTS: None of the 15 Egyptian patients had the 57-kb deletion. Twenty-seven mutant alleles and 12 pathogenic mutations were detected including six novel mutations: two frameshift (c.260_261delTT; p.F87SfsX36, c.1032delCinsTG; p.F345CfsX19), one nonsense (c.734G>A; p.W245fsX), two missense (c.1084G>A; pG362R, c.560A>G; p.K187R), and one intronic splicing mutation (IVS3+5g>t). A novel promoter region mutation (1-593-41C>T) seemed to be detected but was excluded as a pathogenic mutation by quantitative real-time PCR analysis.
CONCLUSIONS: This study could be the basis for future genetic counseling and prenatal diagnosis of patients with nephropathic cystinosis in Egyptian and surrounding populations. The screening for the 57-kb deletion is not recommended anymore outside its geographical distribution, especially in the region of the Middle East. A common Middle Eastern mutation (c.681G>A; E227E) was pointed out and discussed.

Entities:  

Year:  2014        PMID: 24464559      PMCID: PMC4213330          DOI: 10.1007/8904_2013_288

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  31 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Cystinosis: from gene to disease.

Authors:  Vasiliki Kalatzis; Corinne Antignac
Journal:  Nephrol Dial Transplant       Date:  2002-11       Impact factor: 5.992

3.  Detailed studies of growth hormone secretion in cystinosis patients.

Authors:  Martine T P Besouw; Maria Van Dyck; Inge Francois; Elke Van Hoyweghen; Elena N Levtchenko
Journal:  Pediatr Nephrol       Date:  2012-06-05       Impact factor: 3.714

4.  The targeting of cystinosin to the lysosomal membrane requires a tyrosine-based signal and a novel sorting motif.

Authors:  S Cherqui; V Kalatzis; G Trugnan; C Antignac
Journal:  J Biol Chem       Date:  2001-01-09       Impact factor: 5.157

5.  The promoter of a lysosomal membrane transporter gene, CTNS, binds Sp-1, shares sequences with the promoter of an adjacent gene, CARKL, and causes cystinosis if mutated in a critical region.

Authors:  C Phornphutkul; Y Anikster; M Huizing; P Braun; C Brodie; J Y Chou; W A Gahl
Journal:  Am J Hum Genet       Date:  2001-08-14       Impact factor: 11.025

6.  CTNS mutations in an American-based population of cystinosis patients.

Authors:  V Shotelersuk; D Larson; Y Anikster; G McDowell; R Lemons; I Bernardini; J Guo; J Thoene; W A Gahl
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

7.  Analysis of the CTNS gene in patients of German and Swiss origin with nephropathic cystinosis.

Authors:  Michael Kiehntopf; Jörg Schickel; Bärbel von der Gönne; Hans Georg Koch; Andrea Superti-Furga; Beat Steinmann; Thomas Deufel; Erik Harms
Journal:  Hum Mutat       Date:  2002-09       Impact factor: 4.878

8.  Measurement of cystine in granulocytes using liquid chromatography-tandem mass spectrometry.

Authors:  A Chabli; J Aupetit; M Raehm; D Ricquier; B Chadefaux-Vekemans
Journal:  Clin Biochem       Date:  2007-03-13       Impact factor: 3.281

9.  Identification of 14 novel CTNS mutations and characterization of seven splice site mutations associated with cystinosis.

Authors:  Vasiliki Kalatzis; Lola Cohen-Solal; Béatrice Cordier; Yaacov Frishberg; Markus Kemper; E Matti Nuutinen; Eric Legrand; Pierre Cochat; Corinne Antignac
Journal:  Hum Mutat       Date:  2002-12       Impact factor: 4.878

10.  Characterization of CTNS mutations in Arab patients with cystinosis.

Authors:  Mohammed A Aldahmesh; Amal Humeidan; Hamad A Almojalli; Arif O Khan; Mohammed Rajab; Abbas A AL-Abbad; Brian F Meyer; Fowzan S Alkuraya
Journal:  Ophthalmic Genet       Date:  2009-12       Impact factor: 1.803

View more
  17 in total

Review 1.  The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives.

Authors:  Stephanie Cherqui; Pierre J Courtoy
Journal:  Nat Rev Nephrol       Date:  2016-12-19       Impact factor: 28.314

2.  The Clinical and Mutational Spectrum of Turkish Patients with Cystinosis.

Authors:  Rezan Topaloglu; Bora Gulhan; Mihriban İnözü; Nur Canpolat; Alev Yilmaz; Aytül Noyan; İsmail Dursun; İbrahim Gökçe; Metin Kaya Gürgöze; Nurver Akinci; Esra Baskin; Erkin Serdaroğlu; Beltinge Demircioğlu Kiliç; Selçuk Yüksel; Duygu Övünç Hacihamdioğlu; Emine Korkmaz; Mutlu Hayran; Fatih Ozaltin
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-09       Impact factor: 8.237

3.  Common mutation causes cystinosis in the majority of black South African patients.

Authors:  E Patricia Owen; Jenisha Nandhlal; Felicity Leisegang; George Van der Watt; Peter Nourse; Priya Gajjar
Journal:  Pediatr Nephrol       Date:  2014-10-18       Impact factor: 3.714

4.  Clinical and genetic characteristics of Tunisian children with infantile nephropathic cystinosis.

Authors:  Mariem El Younsi; Médiha Trabelsi; Sandra Ben Youssef; Inès Ouertani; Yousra Hammi; Ahlem Achour; Faouzi Maazoul; Maher Kharrat; Tahar Gargah; Ridha M'rad
Journal:  Pediatr Nephrol       Date:  2022-04-20       Impact factor: 3.714

5.  Clinical and neurophysiological characterization of early neuromuscular involvement in children and adolescents with nephropathic cystinosis.

Authors:  Nour Elkhateeb; Rasha Selim; Neveen A Soliman; Fatma M Atia; Ihab Ibrahim Abouelwoun; Mohamed A Elmonem; Rasha Helmy
Journal:  Pediatr Nephrol       Date:  2021-11-18       Impact factor: 3.651

6.  Effect of Storage Conditions on Stability of Ophthalmological Compounded Cysteamine Eye Drops.

Authors:  Ahmed Reda; Ann Van Schepdael; Erwin Adams; Prasanta Paul; David Devolder; Mohamed A Elmonem; Koenraad Veys; Ingele Casteels; Lambertus van den Heuvel; Elena Levtchenko
Journal:  JIMD Rep       Date:  2017-12-07

7.  MYBPC3 Haplotype Linked to Hypertrophic Cardiomyopathy in Rhesus Macaques (Macaca mulatta).

Authors:  Robert F Oldt; Kimberly J Bussey; Matthew L Settles; Joseph N Fass; Jeffrey A Roberts; J Rachel Reader; Srivathsan Komandoor; Victor A Abrich; Sreetharan Kanthaswamy
Journal:  Comp Med       Date:  2020-08-04       Impact factor: 0.982

8.  Lysosomal Storage Disorders in Egyptian Children.

Authors:  Mohamed A Elmonem; Iman G Mahmoud; Dina A Mehaney; Sahar A Sharaf; Sawsan A Hassan; Azza Orabi; Fadia Salem; Marian Y Girgis; Amira El-Badawy; Magy Abdelwahab; Zeinab Salah; Neveen A Soliman; Fayza A Hassan; Laila A Selim
Journal:  Indian J Pediatr       Date:  2016-02-02       Impact factor: 1.967

9.  Molecular characterization of CTNS mutations in Tunisian patients with ocular cystinosis.

Authors:  Latifa Chkioua; Yessine Amri; Chaima Saheli; Wassila Mili; Sameh Mabrouk; Imen Chabchoub; Hela Boudabous; Wissem Ben Azzouz; Hadhami Ben Turkia; Salima Ferchichi; Neji Tebib; Taieb Massoud; Mohamed Ghorbel; Sandrine Laradi
Journal:  Diagn Pathol       Date:  2022-05-06       Impact factor: 3.196

10.  Clinical utility of chitotriosidase enzyme activity in nephropathic cystinosis.

Authors:  Mohamed A Elmonem; Samuel H Makar; Lambertus van den Heuvel; Hanan Abdelaziz; Safaa M Abdelrahman; Xavier Bossuyt; Mirian C Janssen; Elisabeth Am Cornelissen; Dirk J Lefeber; Leo Ab Joosten; Marwa M Nabhan; Fanny O Arcolino; Fayza A Hassan; Héloïse P Gaide Chevronnay; Neveen A Soliman; Elena Levtchenko
Journal:  Orphanet J Rare Dis       Date:  2014-11-19       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.